EP Patent

EP2044085B1 — Penem prodrugs

Assigned to Pfizer Products Inc · Expires 2010-12-29 · 15y expired

What this patent protects

Orally bioavailable prodrugs of sulopenem, e.g., Formula (I) and solvates and hydrates thereof, preparation thereof, formulation thereof, and use to treat and prevent infection in mammals such as humans.

USPTO Abstract

Orally bioavailable prodrugs of sulopenem, e.g., Formula (I) and solvates and hydrates thereof, preparation thereof, formulation thereof, and use to treat and prevent infection in mammals such as humans.

Drugs covered by this patent

Col-Probenecid (probenecid) · Pfizer Inc.

Patent Metadata

Patent number: EP2044085B1
Jurisdiction: EP
Classification: —
Expires: 2010-12-29
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Products Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.